Notice of Closed Meeting, 78968 [2022-28002]

Download as PDF TKELLEY on DSK125TN23PROD with NOTICE 78968 Federal Register / Vol. 87, No. 246 / Friday, December 23, 2022 / Notices • Instructions: Please submit comments only and cite ‘‘Notice BSC– RPM–2022–02’’ in all correspondence related to this notice. Comments received generally will be posted without change to https:// www.regulations.gov, including any personal or business confidential information, or both, provided. To confirm receipt of your comment(s), please check https://www.regulations.gov approximately two to three business days after submission to verify posting. FOR FURTHER INFORMATION CONTACT: Chris Coneeney, Director, Real Property Policy Division, at 202–208–2956, or by email at chris.coneeney@gsa.gov. SUPPLEMENTARY INFORMATION: On April 26, 2019, the Office of Management and Budget (OMB) published OMB memorandum M–19–16, ‘‘Centralized Mission Support Capabilities for the Federal Government’’ (available at https://www.whitehouse.gov/wpcontent/uploads/2019/04/M-19-16.pdf). Mission support business standards, established and agreed to by the CFO Act agencies, using the Federal Integrated Business Framework website at https://ussm.gsa.gov/fibf/, enable the Federal Government to better coordinate on the decision-making needed to determine what mission support services can be adopted and commonly shared. These business standards are an essential first step towards agreement on outcomes, data, and cross-functional end-to-end processes that will drive economies of scale and leverage the government’s buying power. The business standards will be used as the foundation for common mission support services shared by the CFO Act agencies. GSA serves as the real property management business standards lead on the Business Standards Council. The goal of the real property management business standards is to drive real estate management consistency, equity, and standardization across the Federal Government. GSA is seeking public feedback on these draft business data elements, including comments on the understandability of the standards, suggested changes, and usefulness of the draft standards to industry and agencies. Guiding questions in the standards development include: • Do the draft business standards appropriately document the business processes covered? • Are the draft business standards easy to understand? • Will your organization be able to show how your solutions or services, or both, can meet these draft business standards? VerDate Sep<11>2014 20:36 Dec 22, 2022 Jkt 259001 • What would you change about the draft business standards? Is there anything missing? Comments will be used in the formulation of the final real property management business standards. Saul Japson, Acting Associate Administrator, Office of Government-wide Policy, General Services Administration. [FR Doc. 2022–27954 Filed 12–22–22; 8:45 am] announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–28002 Filed 12–22–22; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 6820–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— DD23–001, Birth Defects Study To Evaluate Pregnancy exposureS (BD– STEPS). Dates: March 28–29, 2023. Times: 10 a.m.–5 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Catherine Barrett Ph.D., Scientific Review Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop S107–3, Atlanta, Georgia 30341–3717; Telephone: (404) 718– 7664; Email: CBarrett@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–IP–23– 002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions To Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; Amended Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP–23–002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions to Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; March 29, 2023, 10:00 a.m.– 5:00 p.m., EDT, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Boulevard, Atlanta, Georgia 30329, in the original FRN. The meeting was published in the Federal Register on November 15, 2022, Volume 87, Number 219, pages 68498– 68499. The meeting is being amended to change the meeting date and the room number and should read as follows: Dates: March 29–30, 2023. Times: 10 a.m.–5 p.m., EDT. Place: Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Boulevard, Atlanta, Georgia 30329. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Page 78968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28002]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--DD23-001, Birth Defects Study To 
Evaluate Pregnancy exposureS (BD-STEPS).
    Dates: March 28-29, 2023.
    Times: 10 a.m.-5 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Catherine Barrett Ph.D., 
Scientific Review Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop 
S107-3, Atlanta, Georgia 30341-3717; Telephone: (404) 718-7664; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-28002 Filed 12-22-22; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.